| 注册
首页|期刊导航|中国当代儿科杂志|国内外川崎病指南的异同点解读

国内外川崎病指南的异同点解读

潘炎 谢利剑 焦富勇

中国当代儿科杂志2025,Vol.27Issue(2):144-147,4.
中国当代儿科杂志2025,Vol.27Issue(2):144-147,4.DOI:10.7499/j.issn.1008-8830.2406041

国内外川崎病指南的异同点解读

Interpretation of similarities and differences in Kawasaki disease guidelines at home and abroad

潘炎 1谢利剑 2焦富勇3

作者信息

  • 1. 长江大学附属第一医院儿科,湖北 荆州 434000
  • 2. 复旦大学附属金山医院儿科,上海 201508
  • 3. 陕西省人民医院儿童病院/陕西省川崎病诊疗中心,陕西 西安 710068
  • 折叠

摘要

Abstract

This paper comprehensively compares the Kawasaki disease(KD)guidelines from seven countries/regions,including China,Argentina,Europe,Italy,Japan,Spain,and the United States,as retrieved from the PubMed database.It analyzes the similarities and differences in KD diagnosis and treatment among these guidelines.The results show that all guidelines consistently recommend a single infusion of immunoglobulin at a dosage of 2 g/kg as the first-line treatment for KD,and none advocate for the routine use of methylprednisolone or prednisone as standalone first-line treatment options for KD.However,there are some differences among the guidelines regarding classification,diagnostic criteria,and specific treatment methods for KD.Therefore,it is essential to further strengthen international collaboration in guideline development and conduct multicenter clinical research in the future,aiming to achieve a higher level of expert consensus,thereby promoting the enhancement of KD diagnosis and treatment.

关键词

川崎病/诊断/治疗/指南/解读/儿童

Key words

Kawasaki disease/Diagnosis/Treatment/Guideline/Interpretation/Child

引用本文复制引用

潘炎,谢利剑,焦富勇..国内外川崎病指南的异同点解读[J].中国当代儿科杂志,2025,27(2):144-147,4.

基金项目

湖北省儿科医疗联盟课题(HPAMRP202117) (HPAMRP202117)

上海金山区医学重点专科项目(JSZK2023A04). (JSZK2023A04)

中国当代儿科杂志

OA北大核心

1008-8830

访问量0
|
下载量0
段落导航相关论文